N/A
Completed N=21
Validity and Reliability of the 6-minute Walk Test Over a Distance of 6 Metres in People With Multiple Sclerosis
Source: ClinicalTrials.gov NCT04228328 ↗Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcomePrimary: The 6-minutes Walk Test on 6 Meters — 215.86; 221.57 m
Summary
The objective of this study is to validate a different version of the 6 minutes Walk Test (6minWT), the 6minWT on 6 meters, instead of the 30 meters.
The secondary objectives are to verify the reliability of this new version and to analyze the possible differences between the 6minWT6 and the 6minWT30 (according to speed at half-turn, other parameters: age, gender, height, EDSS score, type of disease, time since relapse).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The 6-minutes Walk Test on 6 Meters |
227.05; 228.90 | — |
| SECONDARY 360 Degree Turn Test (Time) |
6.00 | — |
| SECONDARY 360 Degree Turn Test (Number of Steps) |
8.16 | — |
| SECONDARY 6 Minute Walk Test on 30 Meters |
295.95 | — |
| SECONDARY The 6-minutes Walk Test on 6 Meters |
227.05; 228.90 | — |
Eligibility Criteria
Inclusion Criteria
- adults
- confirmed diagnosis of MS
- Expanded Disability Status Scale score 3 to 6.5 or to be able to walk 30 meters with or without aids
- good understanding of French
- have already completed a 6-minute walk test
- to be able to give consent by signature
Exclusion Criteria
- Lung disease
- Heart disease
- co-morbidity preventing 6minWT
- relapse in the last 3 months
- chronic fatigue ≥ at 8 (Visual Analog Scale- Fatigue)
Data sourced from ClinicalTrials.gov (NCT04228328). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.